Intravenous Fosfomycin Treatment for Carbapenem-Resistant Klebsiella pneumoniae in the United States

作者: Jacques Simkins , Ji Fan , Jose F. Camargo , Laura Aragon , Corey Frederick

DOI: 10.1177/1060028015598326

关键词:

摘要:

参考文章(6)
C. Navarro-San Francisco, M. Mora-Rillo, M.P. Romero-Gómez, F. Moreno-Ramos, A. Rico-Nieto, G. Ruiz-Carrascoso, R. Gómez-Gil, J.R. Arribas-López, J. Mingorance, J.R. Paño-Pardo, Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge Clinical Microbiology and Infection. ,vol. 19, ,(2013) , 10.1111/1469-0691.12091
Julie M. Varghese, Jason A. Roberts, Jeffrey Lipman, Antimicrobial Pharmacokinetic and Pharmacodynamic Issues in the Critically Ill with Severe Sepsis and Septic Shock Critical Care Clinics. ,vol. 27, pp. 19- 34 ,(2011) , 10.1016/J.CCC.2010.09.006
Konstantinos Pontikis, Ilias Karaiskos, Styliani Bastani, George Dimopoulos, Michalis Kalogirou, Maria Katsiari, Angelos Oikonomou, Garyphallia Poulakou, Emmanuel Roilides, Helen Giamarellou, Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria. International Journal of Antimicrobial Agents. ,vol. 43, pp. 52- 59 ,(2014) , 10.1016/J.IJANTIMICAG.2013.09.010
Juliana M. Kyle, Joanna L. Stollings, Katie D. White, Michael J. Noto, Arthur P. Wheeler, Fosfomycin for Multidrug Treatment of Klebsiella pneumoniae Carbapenemase Bacteremia Annals of Pharmacotherapy. ,vol. 49, pp. 366- 367 ,(2015) , 10.1177/1060028014564395
A. Michalopoulos, S. Virtzili, P. Rafailidis, G. Chalevelakis, M. Damala, M.E. Falagas, Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation Clinical Microbiology and Infection. ,vol. 16, pp. 184- 186 ,(2010) , 10.1111/J.1469-0691.2009.02921.X
D. E. Karageorgopoulos, V. Miriagou, L. S. Tzouvelekis, K. Spyridopoulou, G. L. Daikos, Emergence of resistance to fosfomycin used as adjunct therapy in KPC Klebsiella pneumoniae bacteraemia: report of three cases Journal of Antimicrobial Chemotherapy. ,vol. 67, pp. 2777- 2779 ,(2012) , 10.1093/JAC/DKS270